Lyell Immunopharma ($LYEL) Insider Trading & Smart Money Activity

Lyell Immunopharma, Inc. · Biotechnology · Latest filing Oct 12, 2026

Lyell Immunopharma, Inc. ($LYEL) has 2 insider trades on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($3.64K), net -$3.64K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$3.64K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

LYEL insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 1 · $3.64K 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All LYEL insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Aguirre Jarrad MattieuChief Medical Officer Sell (Open-market sale) 422 sh $3.64K Read
Insider Innovative Cellular Therapeutics Holdings Ltd Sell (Other) 76K sh +10.1%+1.7% Read

1W / 1M / 6M = how LYEL moved from the trade or filing date.

Insider trading in LYEL: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Aguirre Jarrad Mattieu Chief Medical Officer 1 -$3.64K Oct 12, 2026
Innovative Cellular Therapeutics Holdings Ltd 1 — Jun 29, 2026

Frequently asked questions

Are LYEL insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $3.64K, a net -$3.64K.

What is the latest insider trade in LYEL?

Aguirre Jarrad Mattieu, Chief Medical Officer filed a sell (open-market sale) of 422 sh worth $3.64K on Oct 12, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text